Comparison of RNA Seq data of gene expression levels in normal and tumor tissues in 32 cancer types reveals that BRF2 is significantly overexpressed in many tumor types, including malignancies of the breast, lung, liver, and kidney (Figure 1). This evidence concerns the gene BRF2 and cancer.